Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL377219 (A-438079) |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
P2X7/P2X purinoceptor 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4805] [GtoPdb: 484] [UniProtKB: Q99572] | ||||||||
ChEMBL | Antagonist activity at human P2X7 receptor in expressed in HEK293 cells assessed as inhibition of BzATP-induced EtBr uptake | B | 6.52 | pIC50 | 300 | nM | IC50 | Eur J Med Chem (2018) 151: 462-481 [PMID:29649742] |
GtoPdb | - | - | 6.9 | pIC50 | ~125 | nM | IC50 | Br J Pharmacol (2007) 151: 571-9 [PMID:17471177] |
ChEMBL | Antagonist activity at human P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of calcium flux by FLIPR | F | 6.9 | pIC50 | 125.89 | nM | IC50 | J. Med. Chem. (2006) 49: 3659-3666 [PMID:16759108] |
ChEMBL | Antagonist activity at P2X7 receptor in human THP1 cells assessed as inhibition of BzATP-induced ethidium uptake | F | 6.9 | pIC50 | 125.89 | nM | IC50 | J. Med. Chem. (2009) 52: 3123-3141 [PMID:19191585] |
ChEMBL | Antagonist activity at human recombinant P2X7 receptor assessed as inhibition of BzATP-induced calcium flux by FLIPR assay | F | 6.91 | pIC50 | 123.03 | nM | IC50 | Bioorg. Med. Chem. Lett. (2008) 18: 2089-2092 [PMID:18272366] |
ChEMBL | Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of benzoylbenzoic ATP-induced calcium production by FLIPR assay | F | 6.91 | pIC50 | 123.03 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 3297-3300 [PMID:21536435] |
P2X7/P2X purinoceptor 7 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2496] [GtoPdb: 484] [UniProtKB: Q64663] | ||||||||
ChEMBL | Antagonist activity at rat P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of calcium flux by FLIPR | F | 6.5 | pIC50 | 316.23 | nM | IC50 | J. Med. Chem. (2006) 49: 3659-3666 [PMID:16759108] |
ChEMBL | Activity at rat P2X7 receptor expressed in HEK cells assessed as effect on BzATP-induced ethidium uptake | B | 6.5 | pIC50 | 316.23 | nM | IC50 | J. Med. Chem. (2009) 52: 3123-3141 [PMID:19191585] |
ChEMBL | Antagonist activity at rat recombinant P2X7 receptor assessed as inhibition of BzATP-induced calcium flux by FLIPR assay | F | 6.51 | pIC50 | 309.03 | nM | IC50 | Bioorg. Med. Chem. Lett. (2008) 18: 2089-2092 [PMID:18272366] |
ChEMBL | Antagonist activity at rat recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of benzoylbenzoic ATP-induced calcium production by FLIPR assay | F | 6.51 | pIC50 | 309.03 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 3297-3300 [PMID:21536435] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]